NOT TOO LATE: Join Our 15th Annual Advocate for Lupus Research Day – THROUGH NEXT WEEK!
Lupus purple was seen throughout the Capitol this week when advocates representing the Lupus Research Alliance visited Congress to...
Stories & News
Study Finds Mycophenolate Mofetil Comparable to Standard Treatment for Pediatric Lupus Nephritis
March 19, 2019
A new study published in Lupus showed that mycophenolate mofetil (MMF) is comparable in effectiveness to the...
Thank you 2019 Half-Marathon Team Life Without Lupus!
Thanks to the Lupus Research Alliance Team Life Without Lupus, with runners who pounded the pavements at the United...
LRA-Supported Researchers Developed a Model to Predict Full-Blown Lupus Nephritis Down the Road
A new study funded by the Lupus Nephritis Trials Network with support from the Lupus Research Alliance has proposed...
Peripheral Nervous System Involvement in Systemic Lupus Erythematosus: A Retrospective Study on Prevalence, Associated Factors and Outcome
A new study published in the peer-reviewed journal Lupus shows that lupus can cause damage to the peripheral nervous...
Lupus Research Alliance and National Minority Quality Forum Release Recommendations to Advance New Lupus Treatments by Increasing Diversity in Clinical Trial Participation
NEW YORK, NY. March 14, 2019. The Lupus Research Alliance (LRA) and the National Minority Quality Forum (NMQF) today...
Frailty Measure Predicts Mortality Risk Among People with Lupus
March 11, 2019
A new study published in Arthritis & Rheumatology by many top lupus clinicians found that a frailty...
Lupus Therapeutics to Test Potential Treatment for Lupus in Takeda Collaboration
New York, NY– March 1. The Lupus Research Alliance and clinical affiliate, Lupus Therapeutics will partner with Takeda Pharmaceutical Company...
Positive Early Results for BIIB059 as New Treatment Strategy
February 28, 2019
Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...
LRA-funded Research Backs New Lupus Nephritis Clinical Trial
February 28, 2019
The biotechnology company Equillium Inc. just announced plans for a Phase 1 study to test the investigational...
Willie Colon Golf Outing
Monday, May 6, 2019 - The Willie Colon Golf Outing benefiting the Lupus Research Alliance Jean Davis Research Grant...
2nd Annual Cars of Longmeadow
We’re so excited to be privileged enough to bring all of these incredible vehicles together for a charity car...